Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma

Urology

Volumn 77, Issue 4, 2011, Pages 842-847

  Komai, Yoshinobu ^a   Fujii, Yasuhisa ^a   Iimura, Yasumasa ^a   Tatokoro, Manabu ^a   Saito, Kazutaka ^a   Otsuka, Yukihiro ^a   Koga, Fumitaka ^a   Arisawa, Chizuru ^a   Kawakami, Satoru ^a   Okuno, Tetsuo ^a   Tsujii, Toshihiko ^a   Kageyama, Yukio ^a   Morimoto, Shinji ^a   Toma, Tsuguhiro ^a   Higashi, Yotsuo ^a   Fukui, Iwao ^a   Kihara, Kazunori ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; JAPANESE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGE FACTORS; CARCINOMA, RENAL CELL; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 79953902526     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.09.062     Document Type: Article

References (27)

1. Frank I, Blute ML, Leibovich BC, et al. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol. 2005;173:1889-1892.
2. Cindolo L, Patard JJ, Chiodini P, et al. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cancer. 2005;104:1362-1371. (Pubitemid 41356151)
3. Schips L, Lipsky K, Zigeuner R, et al. Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients. Urology. 2003;62:1024-1028. (Pubitemid 37510084)
4. Sanchez-Ortiz RF, Rosser CJ, Madsen LT, et al. Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma. J Urol. 2004;171:2160-2165. (Pubitemid 38625426)
5. Geller JI, Argani P, Adeniran A, et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. 2008;112:1607-1616. (Pubitemid 351441175)
6. Thompson RH, Ordonez MA, Iasonos A, et al. Renal cell carcinoma in young and old patients - is there a difference? J Urol. 2008;180:1262-1266.
7. Gillett MD, Cheville JC, Karnes RJ, et al. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol. 2005;173:1893-1896. (Pubitemid 40675205)
8. Scoll BJ, Wong YN, Egleston BL, et al. Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. J Urol. 2009;181:506-511.
9. Jung EJ, Lee HJ, Kwak C, et al. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma. Urology. 2009;73:137-141.
10. Bruder E, Passera O, Harms D, et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol. 2004;28:1117-1132. (Pubitemid 39121606)
11. Komai Y, Fujiwara M, Fujii Y, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res. 2009;15:1170-1176.
12. Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007;31:1149-1160. (Pubitemid 47207116)
13. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192. (Pubitemid 33704203)
14. Camparo P, Vasiliu V, Molinie V, et al. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol. 2008;32:656-670. (Pubitemid 351600831)
15. Pectasides D, Fountzilas G, Aravantinos G, et al. Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience. Int J Gynecol Cancer. 2007;17:1003-1010. (Pubitemid 47414824)
16. Denzinger S, Otto W, Burger M, et al. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates? World J Surg Oncol. 2007;5:16.
17. Voutilainen PE, Multanen MM, Leppaniemi AK, et al. Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age. Thyroidology. 2001;11:953-957. (Pubitemid 33020183)
18. Medeiros LJ, Jones EC, Aizawa S, et al. Grading of renal cell carcinoma: Workgroup. No. 2. Union Internationale Contre le Cancer and the American Joint Committee on Cancer (AJCC). Cancer. 1997;80:990-991. (Pubitemid 27360485)
19. Kim H, Cho NH, Kim DS, et al. Renal cell carcinoma in South Korea: a multicenter study. Hum Pathol. 2004;35:1556-1563. (Pubitemid 40017998)
20. Komai Y, Saito K, Sakai K, et al. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. BJU Int. 2007;99:77-80. (Pubitemid 44915624)
21. Canfield SE, Kamat AM, Sanchez-Ortiz RF, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol. 2006;175:864-869. (Pubitemid 43199998)
22. Blom JH, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol. 2009;55:28-34.
23. Thrasher JB, Paulson DF. Prognostic factors in renal cancer. Urol Clin North Am. 1993;20:247-262. (Pubitemid 23154475)
24. Geller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer. 2004;101:1575-1583. (Pubitemid 39318904)
25. Eggener SE, Yossepowitch O, Pettus JA, et al. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol. 2006;24:3101-3106. (Pubitemid 46638947)
26. Zisman A, Pantuck AJ, Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 2002;20:4559-4566. (Pubitemid 35402959)
27. Kattan MW, Reuter V, Motzer RJ, et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol. 2001;166:63-67. (Pubitemid 32565343)